# Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency

> **NCT00184678** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 161 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00184678
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184678, "Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00184678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*